Safety and efficacy of psychopharmacological agents used to treat the psychiatric sequelae of common neurological disorders

Author： Bernardo Carmina G   Singh Vivek   Thompson Peter M  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.7, Iss.4, 2008-07, pp. : 435-445

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection and Drugs Used to Treat Psychiatric Disorders

By  

Child and Adolescent Psychopharmacology News, Vol. 12, Iss. 4, 2007-08 ,pp. : 1-5

Guilford Publications Inc

Access to resources Recommend Favorite

Editorial (Thematic Issue: Neuroinflammation a Common Link in Neurodegenerative Neurological and Psychiatric Disorders)

By  

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1293-1293

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluation of the pharmacokinetics, safety and clinical efficacy of sertraline used to treat social anxiety

By Mandrioli Roberto   Mercolini Laura   Raggi Maria Augusta  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 9, Iss. 11, 2013-11 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Natural Steroids and Androgen Antagonists used as Neuroprotection in Common Neurological Disorders

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 763-771

Bentham Science Publishers

Access to resources Recommend Favorite

Radiopharmaceuticals in Neurological and Psychiatric Disorders

By  

Current Clinical Pharmacology, Vol. 3, Iss. 2, 2008-05 ,pp. : 99-107

Bentham Science Publishers

Access to resources Recommend Favorite